12 August 2020: Clinical Research
Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
Liwen Hong AD* , Chen Zhang BD* , Rong Fan BC , Lei Wang BC , Zhengting Wang F , Tianyu Zhang AF* , Jie Zhong AEF*DOI: 10.12659/MSM.925018
Med Sci Monit 2020; 26:e925018
Table 4 The role of IFX in PF remission and improvement of social-psychological status.
| Patients treated with IFX n=41 | Patients treated without IFX n=45 | P value | |
|---|---|---|---|
| PF remission, n(%) | 28 (68.3) | 17 (37.8) | 0.005 |
| Improvement of PCDAI | 2.3±2.4 | 0.9±1.9 | 0.003 |
| Improvement of SIBDQ | 2.6±3.9 | 0.7±3.2 | 0.015 |
| Improvement of RSE | 1.1±2.8 | −0.4±2.5 | 0.011 |
| Improvement of BIS | 1.0±2.1 | −0.1±2.1 | 0.020 |